Ultra-high concentration low-viscosity subcutaneous antibody formulations using ionic liquids
- 7 October 2025
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 388 (Pt 1) , 114295
Abstract
No abstract availableKeywords
Funding Information
- Harvard John A Paulson School of Engineering and Applied Sciences
This publication has 44 references indexed in Scilit:
- Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical DevelopmentClinical Pharmacology & Therapeutics, 2024
- Ionic liquids as protein stabilizers for biological and biomedical applications: A reviewBiotechnology Advances, 2022
- Design Principles of Ionic Liquids for Transdermal Drug DeliveryAdvanced Materials, 2019
- Considerations for the Use of Polysorbates in BiopharmaceuticalsPharmaceutical Research, 2018
- Ionic liquids as biocompatible stabilizers of proteinsBiophysical Reviews, 2018
- Key interactions of surfactants in therapeutic protein formulations: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2015
- The history of monoclonal antibody development - Progress, remaining challenges and future innovationsAnnals of Medicine & Surgery, 2014
- Recent Advances in the Applications of Ionic Liquids in Protein Stability and Activity: A ReviewApplied Biochemistry and Biotechnology, 2014
- Hydrophobic salts markedly diminish viscosity of concentrated protein solutionsBiotechnology and Bioengineering, 2010
- Buffer-Dependent Fragmentation of a Humanized Full-Length Monoclonal AntibodyJournal of Pharmaceutical Sciences, 2010